Eulysis

Cambridge, United States Founded: 2010 • Age: 16 yrs
Diabetes management and lifestyle modification services are provided.

About Eulysis

Eulysis is a Healthcare company based in Cambridge (United States) founded in 2010. Diabetes management and lifestyle modification services are provided. Eulysis has raised $4.8 million across 3 funding rounds from investors including Google and 43North. Its focus areas include Biopharma Outsourcing, Logistics & Supply Chain and Packaging. Its legal entity is EULYSIS UK LIMITED. Its competitors include Legacy Pharma Solutions and Nutra-Med Packaging.

Company details

Eulysis was founded in 2010 and is located in Cambridge, United States. Operations center on diabetes care within the healthcare sector, where services including dietary guidance, exercise programs, and medical oversight are delivered. A specialized diet kitchen is maintained to advise on suitable food selections. Educational materials are distributed to support patient self-management and overall health control.

  • Headquarters Cambridge, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website eulysis.com
  • Social LinkedIn X
  • Legal Name Eulysis Uk Limited
Key Metrics
  • Total Equity Funding
    $4.8M (USD)

    in 3 rounds

  • Latest Funding Round
    $3.2M (USD), Series A

    Jun 2015

  • Investors
    Google

    & 1 more

Funding Insights of Eulysis

Eulysis has successfully raised a total of $4.8M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3.2 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.8M
  • Total Rounds 3
  • Last Round Series A β€” $3.2M
  • First Round $500,000

    (Oct 2014)

  • Investors Count 2

All 3 funding rounds of Eulysis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2015$3.2MSeries A––
–
Dec 2014$1.6MSeed––
Oct 2014$500,000Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Eulysis

Eulysis has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Google and 43North.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Seed-stage investments are targeted by 43North in startups.
43north.orgBuffalo, United States
A technology company offering products and services, including search engine, cloud computing, advertising, email, productivity software, and more
1998google.comMountain View, United States
Premium access

Investor details for Eulysis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Eulysis

1 people are tracked at Eulysis (1 in leadership).

NameRoleGroup
Spyridon 'Ross' Tsakas
Founder and PresidentLeadership
Premium access

Complete people profiles for Eulysis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Eulysis

3 dated milestones of Eulysis across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Eulysis is founded.
  2. Funding First funding round of $500K.
  3. Funding Latest funding round, Series A, of $3.2M.

Competitors of Eulysis

Eulysis has 2 listed competitors in our database. They include Legacy Pharma Solutions and Nutra-Med Packaging.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
legacypackaging.com2003Earth, United States331
Contract pharmaceutical packaging company
nutra-med.com1999Hanover, United States
Provider of drugs packaging services
Premium access

Detailed competitors of Eulysis

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Eulysis (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Eulysis

Eulysis was founded in 2010 and raised its 1st funding round 4 years after it was founded.

Eulysis is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Eulysis is a funded company, having raised a total of $4.8M across 3 funding rounds to date. The company's 1st funding round was a Grant of $500K, raised on Oct 2014.

Eulysis was founded in 2010 and is located in Cambridge, United States. Operations center on diabetes care within the healthcare sector, where services including dietary guidance, exercise programs, and medical oversight are delivered. A specialized diet kitchen is maintained to advise on suitable food selections. Educational materials are distributed to support patient self-management and overall health control.

Eulysis's top competitors include Legacy Pharma Solutions and Nutra-Med Packaging.

Eulysis has 2 investors. Key investors include Google, and 43North.

Eulysis operates through Eulysis Uk Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available